The Friday Funny Chronicles
+Columns
The Friday Funny Chronicles
Friday 29 May 2020, 03:35 PM
Columns archive
Hosted content
Your patient with type 2 diabetes is not reaching HbA1c target after lifestyle changes and treatment with metformin. So what next? Dr Rick Cutfield takes an expert look at the second-line treatment options available in New Zealand, including newly funded DPP-4 inhibitor vildagliptin.
Wednesday 19 June 2019, 03:01 AM
Latest issue
20 May 2020
Gallery
At the drive through: COVID-19 community-based assessment centre Pasifika style